In vitro and in silico study demonstrates cytotoxic activity of Lallemantia canescens against HT29 colon cancer cells, highlighting multi-target modulation of survival pathways.
This study investigated the chemical characterization, molecular reactivities, and functional biological behaviors of Lallemantia canescens . Profiling via HPLC identified rosmarinic acid, catechin, and quercetin as the primary phenolic intermediates in methanol and acetone extracts, while headspace solid-phase microextraction coupled with gas chromatography-mass spectrometry (HS-SPME/GC-MS) revealed beta-pinene, myrtenol, and pinocarvone as the predominant volatile constituents. Antioxidant reactivities revealed a higher radical scavenging capacity in the methanol extract. In biological efficacy screens, while both extracts exhibited low-to-moderate antimicrobial activities, the methanol extract demonstrated a more pronounced cytotoxicity against HT29 colon cancer cells. To elucidate the underlying macromolecular interaction mechanisms, in silico molecular docking analysis was conducted against the human PI3K, AKT1, and Bcl-2 target proteins, using Copanlisib, Capivasertib, and Venetoclax as pathway-specific reference controls. The major active intermediates exhibited favorable and comparable binding affinities within the target active sites. Specifically, catechin displayed strong binding energies against AKT1 at − 8.1 kcal/mol and PI3K at − 8.7 kcal/mol, while quercetin demonstrated high affinity against PI3K at − 9.1 kcal/mol, closely aligning with the respective reference inhibitors. These specific molecular interactions suggest that the bio-functional efficacy of L. canescens might be driven by its phenolic-rich chemical composition and potential multi-target modulation of apoptotic and survival pathways.
No takes yet. Share an insight, caveat, or question.
Muhammed Güngören (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: